SABIC’S LEXAN™ CLINIWALL™ AC6200 SHEET PROVIDES ANTI-BACTERIAL, HYGIENIC AND TOUCHABLE WALL CLADDING SOLUTIONS FOR HOSPITALS AND PUBLIC FACILITIES
In answer to the rising need for infection prevention and sanitation control across the world, SABIC is launching LEXAN™ CLINIWALL™ AC6200 Sheet, its new non-chlorinated and non-brominated opaque sheet featuring a pioneering thermoplastics material with anti-bacterial properties in order to provide a hygienic, sanitary solution for interior surfaces to several industries around the world.
“It is important now more than ever for public, industrial and healthcare facilities to be equipped with products that include anti-bacterial properties to ensure the safety of their staff, patients, customers and anyone who may walk through their doors,” says Peter van den Bleek, Product Manager for SABIC. “The specific anti-bacterial (MRSA and E. Coli) additive, incorporated during the production process, makes our newest LEXAN™ CLINIWALL™ sheet a breakthrough material.”
Typical cladding applications include hospitals, clinics, homes for the elderly, primary care centers, sterile rooms, laboratories, pharmaceutical factories, industrial kitchens, storage rooms and refrigeration facilities, schools, restrooms, airports, bus stops, train stations and sports centers.
When independently tested over a 24-hour period at 35 degrees Celsius, LEXAN™ CLINIWALL™ AC6200 Sheet with anti-bacterial shield showed greater than 99.99% reduction in Methicillin-Resistant Staphylococcus Aureus (MRSA) and 99.999% reduction in E. Coli on the surface of the material.
“The anti-bacterial material provides a layer of protection to interior wall cladding against the spread and multiplication of potential bacteria (MRSA and E. Coli), which makes it an excellent choice for patient care and other hygiene-sensitive clinical operations,” Peter says.
LEXAN™ CLINIWALL™ AC6200 Sheet is also a non-chlorinated, non-brominated, and fire resistant opaque material which delivers high impact and wear resistance, and offers excellent stain, blood and urine resistance, as well as chemical resistance to popular cleaning agents like disinfectant Isopropanol (rubbing alcohol), helping to save significantly on maintenance costs.
NOTES TO EDITORS
- SABIC and brands marked with ™ are trademarks of SABIC or its subsidiaries or affiliates.
- SABIC should be written in every instance in all uppercase.
SABIC is a global leader in diversified chemicals headquartered in Riyadh, Saudi Arabia. We manufacture on a global scale in the Americas, Europe, Middle East and Asia Pacific, making distinctly different kinds of products: chemicals, commodity and high performance plastics, agri-nutrients and metals.
We support our customers by identifying and developing opportunities in key end markets such as construction, medical devices, packaging, agri-nutrients, electrical and electronics, transportation and clean energy.
SABIC recorded a net profit of US$ 5.7 billion in 2018. Sales revenues for 2018 totaled US$ 45 billion while total assets stood at US$ 85 billion. Production in 2018 was 75.3 million metric tons.
SABIC has more than 33,000 employees worldwide and operates in around 50 countries. Fostering innovation and a spirit of ingenuity, we have 11,738 global patent filings, and have significant research resources with innovation hubs in five key geographies – USA, Europe, Middle East, South Asia and North Asia.
PHOTOS AND CAPTIONS
Anti-bacterial, hygienic and touchable wall cladding solution at a hospital, through SABIC’s LEXAN™ CLINIWALL™ AC6200 Sheet.
Pre-colored textured LEXAN™ CLINIWALL™ AC6200 Sheet can provide an excellent low-gloss surface finish for the wall cladding, eliminating the need for painting. Its characteristics also help prevent chipping of the surface if impact occurs.
SABIC Media Contacts
T: +31 164 291 616
T: +32 3 31 30 311
This press release and relevant photography can be downloaded from www.PressReleaseFinder.com.
Alternatively, for very high resolution pictures please contact:
Kevin Noels (email@example.com, +32 3 31 30 311).